← Leaderboards
Christopher M Jewell
Baltimore Va Medical Center
$8,528,150
Attributed
$8,528,150
Total exposure
7
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $2.2M · FY2017–25$2.5M$1.9M$1.3M$625K$0
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$8,528,150 · 6
VA$0 · 1
By mechanism
R01$6,883,024 · 4
R44$1,496,118 · 1
U44$149,008 · 1
I01$0 · 1
Top collaborators
No co-investigators on record.
Most similar at Baltimore Va Medical Center
Same institution · by research overlap
- Piotr Walczak$5,252,189
Others in their field
Other Emerging Leaders on “T-Lymphocyte”
- Gautam (george) Mitra · Leidos Biomedical Research, Inc.$53,523,213
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$20,250,477
- Crystal Mackall · Children'S Hosp Of Philadelphia$16,367,876
- Wilton B Williams · Duke University$16,226,847
- Gary Fanger · Rise Therapeutics, Llc$15,372,982
- Aaron Esser-Kahn · University Of Chicago$13,378,548
Research focus
T-LymphocyteImmuneInflammatoryCellsSpecificityPeptidesImmune ResponseDesignLymph NodesAntibodiesPolymersAntigensStructureTechnologyTissuesImmune SystemVaccinesAutoimmune DiseasesCuesProgramsBiocompatible MaterialsCytokineSignal TransductionAutoimmunity
Grant awards (29)
Defining the induction and maintenance of myelin-specific tolerance in T cells and B cells using local lymph node depots$538,057
R01 · FY2025 · AI · contact PI
Tunable Assembly of Regulatory Immune Signals to Promote Myelin-specific Tolerance$0
I01 · FY2025 · VA · contact PI
Manufacturing RNA-based CAR T cells to combat autoantibody-associated autoimmune disorders (AAAD)$1,496,118
R44 · FY2024 · NS · contact PI
Defining the induction and maintenance of myelin-specific tolerance in T cells and B cells using local lymph node depots$554,697
R01 · FY2024 · AI · contact PI
Targeting BCMA+ Cells with RNA-engineered CAR T cells to treat Lupus: A Phase 2 clinical study$149,008
U44 · FY2024 · AI · contact PI
Tunable Assembly of Regulatory Immune Signals to Promote Myelin-specific Tolerance$0
I01 · FY2024 · VA · contact PI
Defining the induction and maintenance of myelin-specific tolerance in T cells and B cells using local lymph node depots$554,697
R01 · FY2023 · AI · contact PI
Tunable Assembly of Regulatory Immune Signals to Promote Myelin-specific Tolerance$0
I01 · FY2023 · VA · contact PI
Defining the induction and maintenance of myelin-specific tolerance in T cells and B cells using local lymph node depots$568,324
R01 · FY2022 · AI · contact PI
Improving multiple sclerosis patient quality of life using microneedle patches to simplify delivery of MS drugs$389,508
R01 · FY2022 · AI · contact PI
Programming immune function through modular assembly of polyionic immune signals$343,257
R01 · FY2022 · EB · contact PI
Programming immune function through modular assembly of polyionic immune signals$58,333
R01 · FY2022 · EB · contact PI
Improving multiple sclerosis patient quality of life using microneedle patches to simplify delivery of MS drugs$394,694
R01 · FY2021 · AI · contact PI
Programming immune function through modular assembly of polyionic immune signals$336,474
R01 · FY2021 · EB · contact PI
Harnessing biomaterials to study the link between local lymph node function and systemic tolerance$331,010
R01 · FY2021 · EB · contact PI
Harnessing biomaterials to study the link between local lymph node function and systemic tolerance$154,472
R01 · FY2021 · EB · contact PI
Programming immune function through modular assembly of polyionic immune signals$116,666
R01 · FY2021 · EB · contact PI
Tunable Assembly of Regulatory Immune Signals to Promote Myelin-specific Tolerance$0
I01 · FY2021 · VA · contact PI
Improving multiple sclerosis patient quality of life using microneedle patches to simplify delivery of MS drugs$399,779
R01 · FY2020 · AI · contact PI
Programming immune function through modular assembly of polyionic immune signals$343,426
R01 · FY2020 · EB · contact PI
Harnessing biomaterials to study the link between local lymph node function and systemic tolerance$337,864
R01 · FY2020 · EB · contact PI
Tunable Assembly of Regulatory Immune Signals to Promote Myelin-specific Tolerance$0
I01 · FY2020 · VA · contact PI
Improving multiple sclerosis patient quality of life using microneedle patches to simplify delivery of MS drugs$418,385
R01 · FY2019 · AI · contact PI
Programming immune function through modular assembly of polyionic immune signals$355,771
R01 · FY2019 · EB · contact PI
Harnessing biomaterials to study the link between local lymph node function and systemic tolerance$337,961
R01 · FY2019 · EB · contact PI
Tunable Assembly of Regulatory Immune Signals to Promote Myelin-specific Tolerance$0
I01 · FY2019 · VA · contact PI
Harnessing biomaterials to study the link between local lymph node function and systemic tolerance$349,649
R01 · FY2018 · EB · contact PI
Tunable Assembly of Regulatory Immune Signals to Promote Myelin-specific Tolerance$0
I01 · FY2018 · VA · contact PI
Tunable Assembly of Regulatory Immune Signals to Promote Myelin-specific Tolerance$0
I01 · FY2017 · VA · contact PI